CMS Approves Iverson Clinical Study of Genetic Testing for Warfarin | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Iverson Genetic Diagnostics said on Monday that it has received approval from the federal agency overseeing Medicare to conduct a clinical study to determine the effect of a genetic test on warfarin dosing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.